
  
    
      
        Background_NNP
        Mammalian_NNP protein_NN phosphatase_NN 5_CD (_( PP_NNP 5_LS )_) and_CC its_PRP$ homolog_NN
        protein_NN phosphatase_NN T_NN 1_CD (_( Ppt_NNP 1_CD p_NN )_) from_IN the_DT yeast_NN 
        Saccharomyces_NNP cerevisiae_NN contain_VBP a_DT
        catalytic_JJ domain_NN structurally_RB related_VBD to_TO the_DT catalytic_JJ
        subunits_NNS of_IN PP_NNP 1_CD ,_, PP_NNP 2_CD A_DT and_CC PP_NNP 2_CD B_NNP ,_, and_CC an_DT N-_NNP terminal_NN domain_NN
        consisting_VBG of_IN multiple_JJ tetratricopeptide_NN repeats_VBZ (_( TPRs_NNP )_) not_RB
        found_VBD in_IN other_JJ members_NNS of_IN this_DT family_NN of_IN phosphatases_NNS [_NN 1_CD 2_CD
        3_CD ]_NN ._. Homologs_NNP have_VBP also_RB been_VBN identified_VBN in_IN 
        Xenopus_NNP laevis_NNS [_NN 4_CD ]_NN ,_, 
        Neurospora_NNP crassa_NN [_NN 5_CD ]_NN ,_, 
        Drosophila_NNP melanogaster_NN [_NN 6_CD ]_NN ,_, 
        Trypanosoma_NNP brucei_NN [_NN 7_CD ]_NN ,_, 
        Plasmodium_NNP falciparum_NN [_NN 8_CD 9_CD ]_NN ,_, and_CC
        cauliflower_NN [_NN 10_CD ]_NN ,_, and_CC homologs_NNS for_IN 
        Caenorhabditis_NNP elegans_NNS ,_,
        Schizosaccharomyces_NNP pombe_NN and_CC 
        Arabidopsis_NNP thaliana_NN are_VBP predicted_VBN
        (_( accession_NN number_NN CAB_NNP 60937_CD ,_, CAA_NNP 17690_CD and_CC AAD_NNP 21727_CD ,_,
        respectively_RB )_) ._.
        Protein_NNP phosphatase_NN 5_CD has_VBZ been_VBN implicated_VBN in_IN the_DT control_NN
        of_IN cell_NN proliferation_NN ,_, in_IN hormonal_NN signal_NN transduction_NN ,_, and_CC
        in_IN hsp_NN 90_CD chaperone_NN function_NN [_NN 3_CD 11_CD 12_CD 13_CD 14_CD 15_CD 16_CD 17_CD ]_NN ._.
        However_RB little_JJ is_VBZ known_VBN about_IN the_DT regulation_NN of_IN PP_NNP 5_CD or_CC its_PRP$
        specific_JJ role_NN in_IN these_DT pathways_NNS ,_, and_CC only_RB one_CD physiological_JJ
        substrate_NN for_IN PP_NNP 5_CD has_VBZ been_VBN identified_VBN to_TO date_NN ,_, the_DT
        apoptosis_NNS signaling_VBG kinase_NN ASK_NNP 1_CD [_NN 13_CD ]_NN ._. PP_NNP 5_CD can_MD be_VB
        activated_VBN by_IN lipid_NN 
        in_IN vitro_NN ,_, and_CC removal_NN of_IN the_DT TPR_NNP
        domain_NN or_CC the_DT C_NNP terminus_JJ generates_VBZ an_DT active_JJ ,_, lipid_NN
        insensitive_JJ form_NN of_IN the_DT enzyme_NN [_NN 18_CD 19_CD 20_CD 21_CD ]_NN ._. PP_NNP 5_CD
        phosphatase_NN activity_NN is_VBZ also_RB altered_VBN by_IN hCRY_NN 2_CD and_CC a_DT
        fragment_NN of_IN hsp_NN 90_CD 
        in_IN vitro_NN [_NN 21_CD 22_CD ]_NN ._. These_DT findings_NNS
        suggest_VBP that_IN PP_NNP 5_CD may_MD be_VB autoinhibited_JJ and_CC that_IN the_DT binding_JJ
        of_IN protein_NN partners_NNS or_CC lipids_NNS to_TO the_DT TPR_NNP domain_NN could_MD
        potentially_RB control_VB PP_NNP 5_CD activity_NN in_IN cells_NNS ,_, however_RB no_DT
        reports_NNS have_VBP yet_RB documented_VBN how_WRB PP_NNP 5_CD is_VBZ regulated_VBN 
        in_IN vivo_NN ._. The_DT activity_NN of_IN PP_NNP 5_CD
        homologs_NNS from_IN cauliflower_NN ,_, 
        T_NN ._. brucei_NN and_CC 
        P_NN ._. falciparum_NN is_VBZ stimulated_VBN by_IN
        polyunsaturated_JJ fatty_NN acids_NNS 
        in_IN vitro_NN [_NN 7_CD 8_CD 9_CD 10_CD ]_NN and_CC removal_NN of_IN
        the_DT TPR_NNP domain_NN from_IN 
        P_NN ._. falciparum_NN PP_NNP 5_CD increases_NNS activity_NN
        to_TO the_DT same_JJ extent_NN as_IN lipid_NN treatment_NN [_NN 8_CD 9_CD ]_NN ._. This_DT
        suggests_VBZ that_IN the_DT TPR_NNP domain_NN plays_VBZ a_DT similar_JJ inhibitory_NN
        role_NN for_IN all_DT PP_NNP 5_CD homologs_NNS ._.
        Genetic_JJ analyses_NNS in_IN 
        S_NNP ._. cerevisiae_NN have_VBP yielded_VBN few_JJ clues_NNS
        about_IN the_DT function_NN of_IN Ppt_NNP 1_CD p_NN ._. Budding_NNP yeast_NN lacking_VBG 
        PPT_NNP 1_CD do_VBP not_RB exhibit_VB obvious_JJ growth_NN
        defects_NNS or_CC detectable_JJ phenotypes_NNS [_NN 2_CD ]_NN ._. Disruption_NNP of_IN 
        PPT_NNP 1_CD together_RB with_IN one_CD of_IN the_DT other_JJ
        known_VBN phosphatases_NNS in_IN budding_VBG yeast_NN also_RB reveals_VBZ no_DT obvious_JJ
        phenotype_NN [_NN 23_CD ]_NN ._. Thus_RB ,_, if_IN Ppt_NNP 1_CD p_NN has_VBZ an_DT essential_JJ function_NN
        in_IN 
        S_NNP ._. cerevisiae_NN ,_, more_JJR than_IN one_CD other_JJ
        phosphatase_NN can_MD also_RB carry_VB out_RP this_DT role_NN ._. In_IN this_DT report_NN we_PRP
        have_VBP characterized_VBN the_DT activity_NN of_IN recombinant_JJ Ppt_NNP 1_CD p_NN ,_,
        analyzed_VBD its_PRP$ expression_NN at_IN the_DT level_NN of_IN protein_NN and_CC mRNA_NN ,_,
        and_CC localized_JJ Ppt_NNP 1_CD p_NN in_IN yeast_NN ._. Ppt_NNP 1_CD p_NN can_MD be_VB activated_VBN by_IN
        lipid_NN ,_, is_VBZ most_RBS highly_RB expressed_VBD in_IN early_JJ log_NN phase_NN growth_NN ,_,
        and_CC is_VBZ present_JJ throughout_IN the_DT cell_NN ._.
      
      
        Results_NNS
        
          Comparison_NNP of_IN Ppt_NNP 1_CD p_NN and_CC PP_NNP 5_CD activity_NN and_CC response_NN
          to_TO lipid_NN treatment_NN
          Recombinant_NNP Ppt_NNP 1_CD p_NN expressed_VBD as_IN a_DT GST-fusion_NNP protein_NN ,_,
          then_RB affinity_NN purified_JJ and_CC released_VBN from_IN GST_NNP by_IN thrombin_NN
          cleavage_NN yielded_VBD a_DT single_JJ band_NN of_IN the_DT expected_VBN molecular_JJ
          weight_NN ,_, 58_CD kDa_NN (_( Fig_NNP ._. 1_LS A_DT )_) ._. When_WRB assayed_JJ side-by-side_RB ,_, the_DT
          basal_NN specific_JJ activities_NNS for_IN recombinant_JJ Ppt_NNP 1_CD p_NN and_CC PP_NNP 5_CD
          were_VBD similar_JJ toward_IN the_DT artificial_JJ substrates_NNS 32_CD P-MBP_NNP and_CC
          32_CD P-_NNP casein_NN ,_, respectively_RB (_( Fig_NNP ._. 1_LS B_NNP )_) ._. Like_IN PP_NNP 5_CD ,_, the_DT
          dephosphorylation_NN of_IN 32_CD P-MBP_NNP by_IN Ppt_NNP 1_CD p_NN was_VBD stimulated_VBN by_IN
          arachidonic_JJ acid_NN and_CC other_JJ unsaturated_JJ fatty_NN acids_NNS ,_, but_CC
          lipids_NNS lacking_VBG either_CC a_DT double_JJ bond_NN or_CC a_DT carboxylate_NN
          group_NN were_VBD not_RB effective_JJ (_( Table_NNP 1_LS )_) ._.
          In_IN the_DT case_NN of_IN pNPP_NN hydrolysis_NNS ,_, others_NNS have_VBP reported_VBN
          both_DT saturated_VBD and_CC unsaturated_JJ fatty_NN acyl_NN coenzyme_NN A_DT
          esters_NNS stimulate_VB PP_NNP 5_CD activity_NN ,_, with_IN concentrations_NNS
          required_VBN for_IN half-maximal_JJ stimulation_NN approximately_RB
          10_CD -_: fold_VB lower_JJR than_IN those_DT of_IN their_PRP$ corresponding_JJ free_JJ
          fatty_NN acids_NNS [_NN 21_CD ]_NN ._. We_PRP therefore_RB tested_VBD whether_IN a_DT
          saturated_VBN fatty_NN acyl_NN coenzyme_NN A_DT ester_NN could_MD also_RB
          stimulate_VB Ppt_NNP 1_CD p_NN ._. Ppt_NNP 1_CD p_NN activity_NN toward_IN 32_CD P-MBP_NNP was_VBD
          stimulated_VBN by_IN arachidoyl_NN coenzyme_NN A_DT in_IN a_DT concentration_NN
          range_NN similar_JJ to_TO that_DT observed_VBD for_IN AA_NN ,_, with_IN half-maximal_JJ
          stimulation_NN occurring_VBG at_IN approximately_RB 50_CD μM_NN for_IN
          arachidoyl_NN coenzyme_NN A_DT and_CC 75_CD μM_NN for_IN AA_NN ._. However_RB ,_, in_IN
          contrast_NN to_TO AA_NN stimulation_NN ,_, Ppt_NNP 1_CD p_NN activity_NN dropped_VBD off_RP
          sharply_RB at_IN 80_CD μM_NN arachidoyl_NN coenzyme_NN A_DT and_CC higher_JJR ._.
          Similar_JJ results_NNS were_VBD observed_VBN for_IN PP_NNP 5_CD (_( data_NNS not_RB shown_VBN )_) ._.
          This_DT suggests_VBZ that_IN double_JJ bonds_NNS are_VBP not_RB required_VBN to_TO
          observe_VB the_DT effect_NN of_IN fatty_NN acyl_NN coenzyme_NN A_DT esters_NNS ._.
          Unlike_IN PP_NNP 5_CD ,_, the_DT activity_NN of_IN Ppt_NNP 1_CD p_NN toward_IN 32_CD P-_NNP casein_NN
          was_VBD not_RB stimulated_VBN by_IN AA_NN ,_, arachidoyl_NN coenzyme_NN A_DT ,_, or_CC
          linoleoyl_NN coenzyme_NN A_DT over_IN a_DT range_NN in_IN concentration_NN from_IN
          10_CD -_: 500_CD μM_NN (_( Fig_NNP ._. 1_LS Band_NNP data_NNS not_RB shown_VBN )_) ._. Other_JJ unsaturated_JJ
          fatty_NN acids_NNS also_RB failed_VBD to_TO stimulate_VB Ppt_NNP 1_CD p_NN activity_NN with_IN
          this_DT substrate_NN (_( Table_NNP 1_LS )_) ._. These_DT data_NNS indicate_VBP that_IN Ppt_NNP 1_CD p_NN
          is_VBZ stimulated_VBN by_IN polyunsaturated_JJ fatty_NN acids_NNS ,_, as_RB well_RB as_IN
          by_IN a_DT saturated_VBN fatty_NN acyl_NN coenzyme_NN A_DT derivative_NN ,_, toward_IN
          some_DT but_CC not_RB all_DT substrates_NNS dephosphorylated_JJ by_IN PP_NNP 5_CD ._.
        
        
          Limited_JJ proteolysis_NNS of_IN Ppt_NNP 1_CD p_NN
          Removal_NNP of_IN the_DT TPR_NNP domain_NN of_IN PP_NNP 5_CD by_IN limited_JJ
          proteolysis_NNS increases_NNS enzyme_NN activity_NN and_CC the_DT TPR_NNP domain_NN
          binds_NNS lipid_NN [_NN 7_CD 8_CD 9_CD 19_CD 20_CD ]_NN ._. Using_VBG conditions_NNS similar_JJ to_TO
          those_DT employed_VBN with_IN PP_NNP 5_CD ,_, digestion_NN of_IN Ppt_NNP 1_CD p_NN with_IN trypsin_NN
          in_IN the_DT absence_NN of_IN lipid_NN produced_VBD a_DT 44_CD kDa_NN catalytic_JJ
          fragment_NN that_WDT was_VBD stable_JJ for_IN at_IN least_JJS 30_CD min_NN and_CC a_DT 20_CD kDa_NN
          fragment_NN that_WDT was_VBD degraded_JJ within_IN 30_CD min_NN (_( Fig_NNP ._. 2_LS A_DT )_) ._.
          N-_NNP terminal_NN sequence_NN analysis_NN showed_VBD that_IN these_DT fragments_NNS
          are_VBP derived_VBN from_IN the_DT catalytic_JJ and_CC the_DT TPR_NNP domains_NNS ,_,
          respectively_RB (_( Fig_NNP ._. 2_LS A_DT ,_, 2_CD B_NNP )_) ._. The_DT crystal_NN structure_NN of_IN the_DT
          PP_NNP 5_CD TPR_NNP domain_NN revealed_VBD three_CD TPRs_NNP followed_VBN by_IN an_DT
          extended_VBN α_NN helix_NN [_NN 24_CD ]_NN ,_, however_RB Ppt_NNP 1_CD p_NN was_VBD originally_RB
          proposed_VBN to_TO contain_VB one_CD additional_JJ TPR_NNP [_NN 2_CD ]_NN ._. The_DT
          pattern_NN of_IN proteolysis_NNS and_CC sites_NNS of_IN cleavage_NN for_IN Ppt_NNP 1_CD p_NN
          are_VBP very_RB similar_JJ to_TO those_DT seen_VBN with_IN PP_NNP 5_CD under_IN these_DT same_JJ
          conditions_NNS [_NN 19_CD ]_NN ._. This_DT indicates_VBZ that_IN Ppt_NNP 1_CD p_NN also_RB
          contains_VBZ an_DT accessible_JJ region_NN linking_VBG the_DT TPR_NNP and_CC
          catalytic_JJ domains_NNS and_CC is_VBZ most_RBS consistent_JJ with_IN the_DT
          presence_NN of_IN three_CD TPRs_NNP in_IN Ppt_NNP 1_CD p_NN ._. Limited_NNP tryptic_JJ
          proteolysis_NNS in_IN the_DT presence_NN of_IN 250_CD μM_NN AA_NN generated_VBD a_DT
          distinct_JJ pattern_NN of_IN fragmentation_NN (_( Fig_NNP ._. 2_LS A_DT )_) ._. A_DT 20_CD kDa_NN
          fragment_NN was_VBD observed_VBN at_IN early_JJ times_NNS ,_, but_CC a_DT series_NN of_IN
          four_CD fragments_NNS ranging_VBG from_IN 14_CD -_: 16_CD kDa_NN appeared_VBD between_IN 10_CD
          and_CC 30_CD min_NN as_IN the_DT amount_NN of_IN the_DT 20_CD kDa_NN fragment_NN
          decreased_VBD ._. These_DT fragments_NNS ,_, which_WDT are_VBP derived_VBN from_IN the_DT
          TPR_NNP domain_NN ,_, were_VBD not_RB observed_VBN in_IN the_DT absence_NN of_IN AA_NN ,_,
          suggesting_VBG that_DT lipid_NN binding_VBG alters_NNS the_DT conformation_NN of_IN
          this_DT domain_NN and_CC its_PRP$ susceptibility_NN to_TO proteolysis_NNS ._. A_DT
          similar_JJ change_NN in_IN susceptibility_NN to_TO proteolysis_NNS upon_IN
          lipid_NN binding_JJ was_VBD observed_VBN with_IN PP_NNP 5_CD [_NN 19_CD ]_NN ._. As_IN with_IN PP_NNP 5_CD ,_,
          only_RB lipids_NNS that_WDT stimulated_VBN 32_CD P-MBP_NNP dephosphorylation_NN
          slowed_VBD degradation_NN of_IN the_DT 20_CD kDa_NN TPR_NNP fragment_NN (_( Table_NNP
          1_LS )_) ._.
          Removal_NNP of_IN the_DT TPR_NNP domain_NN from_IN Ppt_NNP 1_CD p_NN by_IN trypsin_NN
          treatment_NN had_VBD no_DT effect_NN on_IN its_PRP$ activity_NN toward_IN
          32_CD P-_NNP casein_NN ,_, but_CC increased_VBN activity_NN toward_IN 32_CD P-MBP_NNP
          approximately_RB two_CD fold_VB (_( Fig_NNP ._. 2_LS C_NNP )_) ._. AA_NN did_VBD not_RB stimulate_VB
          32_CD P-MBP_NNP dephosphorylation_NN by_IN Ppt_NNP 1_CD p_NN after_IN removal_NN of_IN the_DT
          TPR_NNP domain_NN (_( data_NNS not_RB shown_VBN )_) ._. Thus_RB ,_, lipids_NNS that_WDT activate_VBP
          Ppt_NNP 1_CD p_NN alter_VBP the_DT sensitivity_NN of_IN the_DT TPR_NNP domain_NN to_TO
          proteolysis_NNS ,_, and_CC removal_NN of_IN the_DT TPR_NNP domain_NN causes_VBZ a_DT loss_NN
          of_IN the_DT response_NN of_IN Ppt_NNP 1_CD p_NN to_TO lipid_NN ._. However_RB ,_, removal_NN of_IN
          the_DT TPR_NNP domain_NN only_RB modestly_RB increases_VBZ Ppt_NNP 1_CD p_NN activity_NN ,_, in_IN
          contrast_NN to_TO the_DT 5_CD -_: 25_CD fold_VB elevation_NN reported_VBD after_IN TPR_NNP
          removal_NN from_IN PP_NNP 5_CD [_NN 19_CD 20_CD ]_NN ._. Although_IN we_PRP cannot_NN rule_NN out_RP
          the_DT possibility_NN that_IN proteolyzed_JJ Ppt_NNP 1_CD p_NN is_VBZ unresponsive_JJ to_TO
          lipid_NN because_IN it_PRP is_VBZ unstable_JJ ,_, the_DT observations_NNS that_IN the_DT
          catalytic_JJ fragment_NN remains_VBZ undegraded_JJ and_CC control_NN
          activity_NN is_VBZ not_RB decreased_VBN argue_VB against_IN this_DT possibility_NN ._.
          Alternatively_RB ,_, an_DT inhibitory_NN element_NN in_IN the_DT linker_NN region_NN
          may_MD remain_VB after_IN TPR_NNP domain_NN removal_NN ._.
        
        
          The_DT effect_NN of_IN C-_NNP terminal_NN truncation_NN on_IN Ppt_NNP 1_CD p_NN
          activity_NN
          Removal_NNP of_IN 10_CD -_: 13_CD residues_NNS from_IN the_DT C_NNP terminus_JJ of_IN PP_NNP 5_CD
          results_NNS in_IN a_DT highly_RB active_JJ enzyme_NN that_WDT is_VBZ only_RB modestly_RB
          stimulated_VBN by_IN lipid_NN [_NN 19_CD ]_NN ._. To_TO examine_VB the_DT role_NN of_IN the_DT C_NNP
          terminus_JJ in_IN controlling_VBG Ppt_NNP 1_CD p_NN phosphatase_NN activity_NN ,_, a_DT
          similar_JJ truncation_NN mutant_JJ ,_, Ppt_NNP 1_CD p_NN (_( 1_CD -_: 504_CD )_) ,_, was_VBD expressed_VBN
          and_CC characterized_VBN (_( Fig_NNP ._. 1_LS Aand_NNP 3_LS )_) ._. Compared_VBN to_TO full-length_JJ
          enzyme_NN Ppt_NNP 1_CD p_NN (_( 1_CD -_: 504_CD )_) exhibited_VBN a_DT two-fold_JJ increase_NN in_IN
          control_NN specific_JJ activity_NN with_IN both_DT 32_CD P-_NNP casein_NN and_CC
          32_CD P-MBP_NNP ._. Lipid_NNP did_VBD not_RB stimulate_VB Ppt_NNP 1_CD p_NN (_( 1_CD -_: 504_CD )_) toward_IN
          32_CD P-_NNP casein_NN ,_, but_CC still_RB increased_VBN activity_NN with_IN 32_CD P-MBP_NNP
          12_CD -_: fold_VB ._. In_IN contrast_NN ,_, C-_NNP terminal_NN truncation_NN of_IN PP_NNP 5_CD
          activates_NNS the_DT enzyme_NN as_RB extensively_RB as_IN lipid_NN treatment_NN ,_,
          and_CC little_RB further_JJ activation_NN is_VBZ seen_VBN with_IN lipid_NN [_NN 19_CD ]_NN ._.
          In_IN the_DT case_NN of_IN PP_NNP 5_CD ,_, subtilisin_NN digestion_NN removed_VBD both_DT the_DT
          TPR_NNP domain_NN and_CC the_DT C_NNP terminus_JJ [_NN 19_CD ]_NN ._. The_DT observation_NN
          that_IN C-_NNP terminal_NN truncation_NN increased_VBD Ppt_NNP 1_CD p_NN activity_NN
          toward_IN both_DT 32_CD P-_NNP casein_NN and_CC 32_CD P-MBP_NNP ,_, but_CC subtilisin_NN
          digestion_NN increased_VBD activity_NN only_RB toward_IN 32_CD P-MBP_NNP (_( see_VB
          Fig_NNP ._. 2_LS C_NNP )_) suggests_VBZ that_IN the_DT C_NNP terminus_JJ of_IN Ppt_NNP 1_CD p_NN remained_VBD
          intact_JJ during_IN subtilisin_NN digestion_NN ._. However_RB ,_, mass_NN
          analysis_NN of_IN the_DT subtilisin-derived_JJ catalytic_JJ fragment_NN
          would_MD be_VB required_VBN to_TO confirm_VB this_DT ._.
        
        
          Expression_NNP and_CC localization_NN of_IN HA-Ppt_NNP 1_CD p_NN in_IN yeast_NN
          cells_NNS
          To_TO examine_VB when_WRB Ppt_NNP 1_CD p_NN is_VBZ expressed_VBN and_CC where_WRB it_PRP is_VBZ
          localized_VBN ,_, a_DT yeast_NN strain_NN (_( WHT_NNP 4_CD -_: 1_LS )_) was_VBD generated_VBN in_IN which_WDT
          the_DT 
          PPT_NNP 1_CD gene_NN was_VBD replaced_VBN with_IN cDNA_NN
          encoding_VBG hemagglutinin-tagged_JJ Ppt_NNP 1_CD p_NN (_( HA-Ppt_NNP 1_CD p_NN )_) ._.
          Immunoblotting_NNP showed_VBD that_IN HA-Ppt_NNP 1_CD p_NN levels_NNS were_VBD highest_JJS
          in_IN early_JJ log_NN phase_NN ,_, and_CC then_RB decreased_VBD dramatically_RB
          during_IN the_DT stationary_JJ phase_NN (_( Fig_NNP ._. 4_LS A_DT ,_, 4_CD B_NNP )_) ._. Northern_JJ
          analysis_NN showed_VBD that_IN the_DT 
          PPT_NNP 1_CD mRNA_NN levels_NNS also_RB increased_VBN in_IN
          early_JJ log_NN phase_NN and_CC decreased_VBD as_IN the_DT cell_NN division_NN
          decreased_VBD upon_IN entering_VBG the_DT stationary_JJ phase_NN (_( Fig_NNP ._. 4_LS C_NNP )_) ,_,
          correlating_VBG with_IN protein_NN expression_NN ._. The_DT pattern_NN of_IN 
          PPT_NNP 1_CD gene_NN expression_NN was_VBD identical_JJ
          in_IN wild-type_JJ cells_NNS and_CC cells_NNS expressing_VBG HA-Ppt_NNP 1_CD p_NN ,_,
          indicating_VBG that_IN the_DT epitope_NN tag_NN did_VBD not_RB alter_VB
          transcription_NN or_CC message_NN stability_NN (_( data_NNS not_RB shown_VBN )_) ._.
          Cells_NNP in_IN early_JJ log_NN phase_NN growth_NN when_WRB 
          PPT_NNP 1_CD gene_NN expression_NN was_VBD maximal_NN
          were_VBD used_VBN to_TO localize_NN HA-Ppt_NNP 1_CD p_NN ._. Indirect_JJ
          immunofluorescence_NN was_VBD required_VBN to_TO detect_VB HA-Ppt_NNP 1_CD p_NN ._.
          Fluorescence_NNP microscopy_NN indicated_VBD that_IN HA-Ppt_NNP 1_CD p_NN was_VBD
          present_JJ throughout_IN the_DT cell_NN ,_, including_VBG the_DT nucleus_NN (_( Fig_NNP ._.
          5_LS A_DT )_) ._. Localization_NNP and_CC staining_VBG intensity_NN did_VBD not_RB appear_VB
          to_TO change_VB as_IN a_DT function_NN of_IN bud_NN size_NN or_CC morphology_NN ,_,
          suggesting_VBG that_IN Ppt_NNP 1_CD p_NN expression_NN and_CC localization_NN is_VBZ not_RB
          cell_NN cycle_NN dependent_JJ ._.
          To_TO confirm_VB that_IN the_DT indirect_JJ immunofluorescence_NN
          procedure_NN did_VBD not_RB generate_VB artifacts_NNS ,_, the_DT localization_NN of_IN
          the_DT spindle_NN pole_NN body_NN protein_NN Spc_NNP 42_CD p_NN was_VBD also_RB examined_VBN by_IN
          this_DT method_NN ._. A_DT yeast_NN centromeric_JJ plasmid_NN encoding_VBG the_DT
          fusion_NN protein_NN Spc_NNP 42_CD p-_NN EGFP_NNP was_VBD transformed_VBN into_IN W_NNP 303_CD
          cells_NNS ._. Direct_JJ fluorescence_NN from_IN EGFP_NNP and_CC indirect_JJ
          immunofluorescence_NN using_VBG the_DT amplification_NN protocol_NN with_IN
          anti-_NN EGFP_NNP antibody_NN were_VBD compared_VBN ._. Both_DT signals_NNS revealed_VBD
          specific_JJ localization_NN of_IN Spc_NNP 42_CD p-_NN EGFP_NNP to_TO the_DT spindle_NN pole_NN
          body_NN (_( Fig_NNP ._. 5_LS B_NNP )_) ._.
          When_WRB HA-Ppt_NNP 1_CD p_NN or_CC EGFP-Ppt_NNP 1_CD p_NN was_VBD overexpressed_JJ from_IN the_DT
          
          GAL_NNP 1_CD promoter_NN in_IN a_DT centromeric_JJ or_CC
          episomal_NN plasmid_NN ,_, respectively_RB ,_, indirect_JJ
          immunofluorescence_NN of_IN HA-Ppt_NNP 1_CD p_NN or_CC direct_JJ fluorescence_NN
          from_IN EGFP-Ppt_NNP 1_CD p_NN showed_VBD that_IN both_DT proteins_NNS were_VBD also_RB
          localized_JJ throughout_IN the_DT cell_NN ._.
        
      
      
        Discussion_NNP
        PP_NNP 5_CD and_CC its_PRP$ homologs_NNS in_IN other_JJ species_NNS represent_VBP a_DT
        subfamily_RB of_IN PPP_NNP enzymes_NNS distinguished_VBN by_IN the_DT presence_NN of_IN
        an_DT N-_NNP terminal_NN domain_NN containing_VBG multiple_JJ TPR_NNP repeats_VBZ ._. Ppt_NNP 1_CD p_NN
        from_IN the_DT yeast_NN 
        Saccharomyces_NNP cerevisiae_NN was_VBD the_DT
        first_JJ homolog_NN of_IN mammalian_JJ PP_NNP 5_CD to_TO be_VB described_VBN ._. Thus_RB far_RB ,_,
        genetic_JJ approaches_NNS have_VBP not_RB revealed_VBN functions_NNS for_IN budding_VBG
        yeast_NN Ppt_NNP 1_CD p_NN ._. In_IN this_DT report_NN ,_, we_PRP have_VBP characterized_VBN Ppt_NNP 1_CD p_NN
        activity_NN 
        in_IN vitro_NN and_CC examined_VBD its_PRP$
        expression_NN ._.
        In_IN the_DT case_NN of_IN mammalian_JJ PP_NNP 5_CD ,_, results_NNS from_IN lipid_NN
        stimulation_NN and_CC binding_JJ ,_, limited_JJ proteolysis_NNS and_CC truncation_NN
        studies_NNS taken_VBN together_RB suggest_VBP the_DT TPR_NNP domain_NN and_CC the_DT C_NNP
        terminus_JJ inhibit_VB PP_NNP 5_CD activity_NN in_IN a_DT coordinated_VBN manner_NN and_CC
        that_DT lipid_NN binding_VBG to_TO the_DT TPR_NNP domain_NN activates_NNS the_DT enzyme_NN 
        in_IN vitro_NN [_NN 18_CD 19_CD 20_CD ]_NN ._. In_IN the_DT
        present_JJ study_NN we_PRP used_VBD assay_NN conditions_NNS for_IN Ppt_NNP 1_CD p_NN identical_JJ
        to_TO those_DT in_IN which_WDT PP_NNP 5_CD was_VBD shown_VBN to_TO be_VB activated_VBN by_IN removal_NN
        of_IN the_DT TPR_NNP or_CC C-_NNP terminal_NN regions_NNS [_NN 19_CD ]_NN ._. Under_IN these_DT
        conditions_NNS Ppt_NNP 1_CD p_NN is_VBZ also_RB stimulated_VBN by_IN lipids_NNS toward_IN
        32_CD P-MBP_NNP ,_, and_CC activating_VBG lipids_NNS slow_JJ TPR_NNP domain_NN proteolysis_NNS ._.
        These_DT results_NNS indicate_VBP that_IN Ppt_NNP 1_CD p_NN has_VBZ a_DT similar_JJ domain_NN
        structure_NN to_TO PP_NNP 5_CD and_CC is_VBZ activated_VBN in_IN a_DT similar_JJ manner_NN by_IN
        lipid_NN binding_VBG to_TO the_DT TPR_NNP domain_NN ._. Removal_NNP of_IN the_DT TPR_NNP domain_NN
        prevents_VBZ stimulation_NN by_IN lipid_NN ,_, but_CC only_RB modestly_RB increases_VBZ
        Ppt_NNP 1_CD p_NN activity_NN ._. Carboxyl-terminal_NNP truncation_NN modestly_RB
        increases_VBZ Ppt_NNP 1_CD p_NN activity_NN toward_IN both_DT 32_CD P-MBP_NNP and_CC
        32_CD P-_NNP casein_NN ,_, and_CC does_VBZ not_RB prevent_VB further_JJ lipid_NN stimulation_NN
        of_IN 32_CD P-MBP_NNP dephosphorylation_NN ._. These_DT results_NNS distinguish_VB
        Ppt_NNP 1_CD p_NN from_IN mammalian_JJ PP_NNP 5_CD and_CC suggest_VBP that_IN the_DT C_NNP terminus_JJ is_VBZ
        less_RBR important_JJ in_IN controlling_VBG Ppt_NNP 1_CD p_NN activity_NN ._. Although_IN more_JJR
        work_NN will_MD be_VB required_VBN to_TO determine_VB its_PRP$ role_NN in_IN lipid_NN
        stimulation_NN ,_, removal_NN of_IN the_DT TPR_NNP domain_NN had_VBD only_RB a_DT small_JJ
        effect_NN on_IN Ppt_NNP 1_CD p_NN activation_NN ._. Ppt_NNP 1_CD p_NN contains_VBZ two_CD short_JJ
        stretches_NNS of_IN amino_JJ acids_NNS ,_, a_DT 15_CD -_: residue_NN sequence_NN between_IN the_DT
        linker_NN helix_NN and_CC the_DT catalytic_JJ domain_NN (_( residues_NNS 174_CD -_: 188_CD )_) ,_,
        and_CC a_DT ten-residue_JJ sequence_NN just_RB preceding_VBG the_DT extreme_JJ C_NNP
        terminus_JJ (_( residues_NNS 474_CD -_: 484_CD )_) ,_, that_WDT are_VBP not_RB found_VBN in_IN other_JJ
        PP_NNP 5_CD homologs_NNS reported_VBD thus_RB far_RB (_( [_NN 1_CD 2_CD 3_CD 4_CD 5_CD 6_CD 7_CD 8_CD 9_CD 10_CD ]_NN ,_,
        and_CC accession_NN numbers_NNS CAB_NNP 60937_CD ,_, CAA_NNP 17690_CD and_CC AAD_NNP 21727_CD )_) ._. The_DT
        presence_NN of_IN these_DT additional_JJ sequences_NNS in_IN Ppt_NNP 1_CD p_NN may_MD
        underlie_VB the_DT differences_NNS in_IN the_DT responses_NNS of_IN Ppt_NNP 1_CD p_NN and_CC PP_NNP 5_CD
        to_TO N_NNP or_CC C-_NNP terminal_NN truncation_NN ._. Additional_JJ studies_NNS will_MD be_VB
        required_VBN to_TO determine_VB if_IN our_PRP$ observations_NNS reflect_VBP
        structural_JJ and_CC regulatory_JJ properties_NNS unique_JJ to_TO Ppt_NNP 1_CD p_NN ._.
        Ppt_NNP 1_CD p_NN and_CC PP_NNP 5_CD exhibit_NN similar_JJ specific_JJ activities_NNS toward_IN
        32_CD P-_NNP casein_NN in_IN the_DT absence_NN of_IN lipid_NN ._. However_RB Ppt_NNP 1_CD p_NN activity_NN
        toward_IN this_DT substrate_NN was_VBD not_RB stimulated_VBN by_IN lipids_NNS ._. These_DT
        results_NNS highlight_NN the_DT fact_NN that_IN PPP_NNP enzymes_NNS often_RB exhibit_NN
        substrate_NN specific_JJ effects_NNS 
        in_IN vitro_NN and_CC that_IN the_DT use_NN of_IN a_DT single_JJ
        substrate_NN to_TO study_VB this_DT family_NN of_IN enzymes_NNS can_MD be_VB
        misleading_JJ ._. Like_IN PP_NNP 5_CD ,_, the_DT control_NN activity_NN of_IN Ppt_NNP 1_CD p_NN is_VBZ low_JJ
        toward_IN the_DT commonly_RB used_VBN artificial_JJ substrates_NNS such_JJ as_IN
        32_CD P-_NNP casein_NN and_CC 32_CD P-MBP_NNP compared_VBD to_TO other_JJ PPP_NNP enzymes_NNS [_NN 18_CD ]_NN
        ._. Thus_RB ,_, it_PRP is_VBZ not_RB clear_JJ whether_IN the_DT selective_JJ lipid_NN
        stimulation_NN of_IN Ppt_NNP 1_CD p_NN toward_IN 32_CD P-MBP_NNP reflects_VBZ a_DT
        substrate-directed_JJ effect_NN ,_, or_CC whether_IN 32_CD P-_NNP casein_NN is_VBZ simply_RB
        a_DT poor_JJ substrate_NN for_IN Ppt_NNP 1_CD p_NN ._. Egloff_NNP and_CC colleagues_NNS
        identified_VBD seven_CD acidic_JJ surface_NN residues_NNS on_IN the_DT catalytic_JJ
        face_NN of_IN PP_NNP 1_CD c_SYM γ_NN that_WDT are_VBP replaced_VBN by_IN neutral_JJ or_CC basic_JJ
        residues_NNS in_IN PP_NNP 2_CD A_DT [_NN 25_CD ]_NN ._. They_PRP suggest_VBP the_DT presence_NN of_IN
        these_DT acidic_JJ residues_NNS in_IN PP_NNP 1_CD c_SYM γ_NN may_MD explain_VB why_WRB casein_NN is_VBZ a_DT
        good_JJ substrate_NN for_IN PP_NNP 2_CD A_DT ,_, but_CC not_RB for_IN PP_NNP 1_CD ._. Based_VBN on_IN a_DT
        sequence_NN alignment_NN with_IN PP_NNP 1_CD c_SYM γ_NN ,_, these_DT seven_CD acidic_JJ residues_NNS
        are_VBP not_RB conserved_JJ in_IN Ppt_NNP 1_CD p_NN ._. Using_VBG the_DT program_NN Modeller_NNP [_NN 26_CD
        ]_NN ,_, a_DT homology_NN model_NN of_IN the_DT catalytic_JJ domain_NN of_IN Ppt_NNP 1_CD p_NN was_VBD
        built_VBN based_VBN on_IN three_CD PP_NNP 1_CD structures_NNS -_: PDB_NNP
        http_NN :_: /_NN /_NN www_NN ._. pdb_NN ._. org_NN [_NN 27_CD ]_NN codes_NNS 1_CD FJM_NNP [_NN 28_CD ]_NN ,_, 1_CD IT_PRP 6_CD [_NN 29_CD ]_NN
        and_CC 1_CD JK_NNP 7_CD [_NN 30_CD ]_NN ._. This_DT model_NN shows_VBZ that_IN the_DT catalytic_JJ face_NN
        of_IN Ppt_NNP 1_CD p_NN is_VBZ generally_RB less_RBR acidic_JJ than_IN that_DT of_IN PP_NNP 1_CD c_SYM γ_NN and_CC
        does_VBZ not_RB indicate_VB the_DT presence_NN of_IN other_JJ acidic_JJ residues_NNS
        that_WDT could_MD act_VB in_IN the_DT same_JJ fashion_NN as_IN those_DT on_IN PP_NNP 1_CD c_SYM γ_NN ._. Thus_RB
        the_DT reason_NN for_IN low_JJ Ppt_NNP 1_CD p_NN activity_NN toward_IN this_DT acidic_JJ
        substrate_NN may_MD be_VB more_RBR complex_JJ than_IN can_MD be_VB explained_VBN by_IN
        electrostatic_JJ repulsion_NN ._.
        Others_NNS have_VBP proposed_VBN that_DT fatty_NN acyl_NN coenzyme_NN A_DT esters_NNS
        are_VBP potential_JJ physiologic_JJ regulators_NNS of_IN PP_NNP 5_CD ,_, since_IN these_DT
        compounds_NNS stimulate_VB pNPP_NN hydrolysis_NNS by_IN PP_NNP 5_CD 
        in_IN vitro_NN at_IN physiologically_RB relevant_JJ
        concentrations_NNS and_CC are_VBP approximately_RB 10_CD -_: fold_VB more_RBR potent_JJ
        than_IN their_PRP$ free_JJ fatty_NN acid_NN counterparts_NNS [_NN 21_CD ]_NN ._. Although_IN
        we_PRP confirmed_VBD this_DT observation_NN using_VBG PP_NNP 5_CD and_CC pNPP_NN (_( data_NNS not_RB
        shown_VBN )_) ,_, in_IN our_PRP$ hands_VBZ similar_JJ levels_NNS of_IN AA_NN and_CC arachidoyl_NN
        coenzyme_NN A_DT were_VBD required_VBN for_IN half-maximal_JJ stimulation_NN of_IN
        32_CD P-MBP_NNP dephosphorylation_NN in_IN the_DT case_NN of_IN both_DT Ppt_NNP 1_CD p_NN and_CC
        PP_NNP 5_CD ._. Although_IN more_JJR work_NN is_VBZ required_VBN to_TO examine_VB this_DT issue_NN
        thoroughly_RB ,_, our_PRP$ results_NNS suggest_VBP that_IN the_DT large_JJ differences_NNS
        in_IN potency_NN between_IN free_JJ fatty_NN acids_NNS and_CC fatty_NN acyl_NN coenzyme_NN
        A_DT esters_NNS seen_VBN using_VBG pNPP_NN may_MD not_RB extend_VB to_TO all_DT protein_NN
        substrates_NNS ._. In_IN addition_NN ,_, it_PRP will_MD be_VB important_JJ to_TO determine_VB
        if_IN lipids_NNS in_IN any_DT form_NN play_VBP a_DT role_NN in_IN the_DT regulation_NN of_IN PP_NNP 5_CD
        or_CC Ppt_NNP 1_CD p_NN 
        in_IN vivo_NN ._.
        Ppt_NNP 1_CD p_NN was_VBD present_JJ in_IN both_DT the_DT nucleus_NN and_CC cytoplasm_NN of_IN 
        S_NNP ._. cerevisiae_NN ._. No_DT difference_NN in_IN
        compartmentalization_NN or_CC staining_VBG intensity_NN in_IN cells_NNS was_VBD
        observed_VBN as_IN a_DT function_NN of_IN cell_NN or_CC bud_NN size_NN ._. This_DT suggests_VBZ
        that_IN the_DT level_NN or_CC localization_NN of_IN Ppt_NNP 1_CD p_NN is_VBZ not_RB controlled_VBN
        as_IN a_DT function_NN of_IN cell_NN cycle_NN progression_NN ._. Both_DT nuclear_JJ and_CC
        cytoplasmic_JJ localization_NN have_VBP been_VBN reported_VBN for_IN other_JJ PP_NNP 5_CD
        homologs_NNS ._. In_IN some_DT cases_NNS ,_, including_VBG 
        P_NN ._. falciparum_NN and_CC HeLa_NNP cells_NNS ,_, nuclear_JJ
        staining_VBG appeared_VBN more_RBR intense_JJ than_IN cytoplasmic_JJ staining_VBG [_NN
        2_CD 9_CD ]_NN ._. Based_VBN on_IN studies_NNS with_IN heterologously_RB expressed_VBD
        human_JJ PP_NNP 5_CD -_: GFP_NNP fusion_NN proteins_NNS ,_, it_PRP has_VBZ been_VBN proposed_VBN that_IN
        nuclear_JJ localization_NN requires_VBZ a_DT stretch_NN of_IN sequence_NN in_IN the_DT
        C_NNP terminus_JJ [_NN 31_CD ]_NN ._. However_RB ,_, other_JJ sequences_NNS or_CC signals_NNS are_VBP
        also_RB likely_JJ to_TO contribute_VB to_TO nuclear_JJ localization_NN of_IN PP_NNP 5_CD
        and_CC its_PRP$ homologs_NNS ,_, since_IN rat_NN and_CC mouse_NN PP_NNP 5_CD ,_, which_WDT are_VBP
        identical_JJ to_TO human_JJ PP_NNP 5_CD in_IN this_DT region_NN do_VBP not_RB appear_VB to_TO be_VB
        nuclear_JJ in_IN all_DT cell_NN types_NNS [_NN 32_CD 33_CD ]_NN ._. In_IN addition_NN 
        P_NN ._. falciparum_NN PP_NNP 5_CD is_VBZ primarily_RB
        nuclear_JJ [_NN 9_CD ]_NN ,_, although_IN it_PRP is_VBZ not_RB well_RB conserved_JJ in_IN the_DT
        relevant_JJ C-_NNP terminal_NN region_NN but_CC contains_VBZ a_DT potential_JJ
        bipartite_NN nuclear_JJ localization_NN signal_NN not_RB found_VBD in_IN other_JJ
        PP_NNP 5_CD sequences_NNS reported_VBD thus_RB far_RB ._. The_DT functional_JJ
        significance_NN of_IN differential_NN localization_NN is_VBZ not_RB known_VBN at_IN
        this_DT time_NN ._.
        Ppt_NNP 1_CD p_NN levels_NNS are_VBP highest_JJS during_IN periods_NNS of_IN rapid_JJ growth_NN
        and_CC drop_NN off_IN when_WRB growth_NN slows_VBZ (_( Fig_NNP ._. 4_LS B_NNP )_) ,_, raising_VBG the_DT
        possibility_NN that_IN this_DT enzyme_NN may_MD have_VB a_DT role_NN in_IN controlling_VBG
        cell_NN growth_NN [_NN 34_CD ]_NN and_CC its_PRP$ expression_NN may_MD be_VB regulated_VBN by_IN a_DT
        metabolic_JJ or_CC nutritional_JJ signal_NN [_NN 35_CD ]_NN ._. The_DT observation_NN
        that_IN Ppt_NNP 1_CD p_NN levels_NNS rose_VBD and_CC fell_VBD in_IN parallel_JJ with_IN mRNA_NN
        levels_NNS suggests_VBZ that_IN Ppt_NNP 1_CD p_NN expression_NN is_VBZ primarily_RB
        controlled_VBN at_IN the_DT level_NN of_IN gene_NN transcription_NN ._. Studies_NNS of_IN
        PP_NNP 5_CD and_CC its_PRP$ homologs_NNS in_IN cultured_JJ cells_NNS and_CC various_JJ
        organisms_NNS also_RB suggest_VBP it_PRP may_MD play_VB a_DT role_NN in_IN development_NN [_NN
        5_CD 6_CD ]_NN or_CC during_IN rapid_JJ cell_NN growth_NN [_NN 2_CD 7_CD ]_NN ._.
      
      
        Conclusions_NNP
        Ppt_NNP 1_CD p_NN shares_NNS several_JJ biochemical_JJ properties_NNS with_IN PP_NNP 5_CD and_CC
        other_JJ homologs_NNS ,_, including_VBG a_DT similar_JJ domain_NN structure_NN and_CC
        stimulation_NN by_IN lipid_NN 
        in_IN vitro_NN ._. Unlike_IN PP_NNP 5_CD ,_, Ppt_NNP 1_CD p_NN is_VBZ not_RB
        fully_RB activated_VBN by_IN removal_NN of_IN the_DT TPR_NNP domain_NN or_CC by_IN removal_NN
        of_IN 9_CD C-_NNP terminal_NN residues_NNS ,_, suggesting_VBG that_IN these_DT regions_NNS may_MD
        not_RB play_VB an_DT autoinhibitory_NN role_NN in_IN Ppt_NNP 1_CD p_NN ._. Ppt_NNP 1_CD p_NN is_VBZ
        expressed_VBN in_IN early_JJ log_NN phase_NN growth_NN and_CC decreases_NNS
        dramatically_RB as_IN cells_NNS approach_VBP the_DT stationary_JJ phase_NN ,_,
        suggesting_VBG that_IN Ppt_NNP 1_CD p_NN could_MD play_VB a_DT role_NN in_IN cell_NN growth_NN or_CC
        may_MD be_VB controlled_VBN by_IN metabolic_JJ or_CC nutritional_JJ signals_NNS ._. Like_IN
        PP_NNP 5_CD ,_, the_DT observation_NN that_IN Ppt_NNP 1_CD p_NN is_VBZ localized_VBN in_IN both_DT the_DT
        nucleus_NN and_CC cytoplasm_NN implies_VBZ that_IN it_PRP may_MD function_VB in_IN
        several_JJ subcellular_NN compartments_NNS ._.
        Although_IN our_PRP$ findings_NNS suggest_VBP some_DT differences_NNS may_MD exist_VB
        in_IN regulatory_JJ properties_NNS of_IN Ppt_NNP 1_CD p_NN and_CC PP_NNP 5_CD ,_, many_JJ biochemical_JJ
        and_CC cellular_JJ properties_NNS are_VBP shared_VBN ._. In_IN addition_NN a_DT recent_JJ
        report_NN has_VBZ shown_VBN that_IN Ppt_NNP 1_CD p_NN is_VBZ co-purified_JJ with_IN Hsp_NNP 82_CD p_NN and_CC
        Hsc_NNP 82_CD p_NN ,_, the_DT 
        S_NNP ._. cerevisiae_NN homologs_NNS of_IN hsp_NN 90_CD [_NN 36_CD
        ]_NN ,_, indicating_VBG that_IN Ppt_NNP 1_CD p_NN and_CC PP_NNP 5_CD have_VBP at_IN least_JJS one_CD common_JJ
        protein_NN partner_NN and_CC suggesting_VBG that_IN ,_, like_IN PP_NNP 5_CD ,_, Ppt_NNP 1_CD p_NN
        functions_NNS in_IN chaperone_NN complexes_NNS ._. Thus_RB ,_, 
        S_NNP ._. cerevisiae_NN Ppt_NNP 1_CD p_NN is_VBZ likely_JJ to_TO be_VB a_DT
        valuable_JJ model_NN for_IN probing_VBG the_DT cellular_JJ role_NN of_IN PP_NNP 5_CD ._.
      
      
        Methods_NNP
        
          Materials_NNS
          Restriction_NNP enzymes_NNS and_CC DNA_NNP modifying_VBG enzymes_NNS were_VBD
          purchased_VBN from_IN New_NNP England_NNP Biolabs_NNP ,_, Promega_NNP or_CC Gibco_NNP BRL_NNP ._.
          Reagents_NNP for_IN bacterial_JJ and_CC yeast_NN culture_NN were_VBD purchased_VBN
          from_IN Difco_NNP ._. All_DT other_JJ materials_NNS were_VBD from_IN Sigma_NNP unless_IN
          otherwise_RB noted_VBD ._. The_DT yeast_NN centromeric_JJ plasmid_NN encoding_VBG
          the_DT Spc_NNP 42_CD p-_NN EGFP_NNP fusion_NN protein_NN was_VBD a_DT kind_NN gift_NN from_IN
          Younghoon_NNP Oh_UH and_CC Dr_NNP ._. Harry_NNP Charbonneau_NNP (_( Department_NNP of_IN
          Biochemistry_NNP ,_, Purdue_NNP University_NNP )_) ._.
        
        
          Cloning_NNP and_CC expression_NN of_IN recombinant_JJ Ppt_NNP 1_CD p_NN ,_, Ppt_NNP 1_CD p_NN
          (_( 1_CD -_: 504_CD )_) ,_, and_CC PP_NNP 5_CD in_IN E_NNP ._. coli_NNS
          PP_NNP 5_CD was_VBD expressed_VBN and_CC purified_JJ as_IN described_VBN previously_RB
          [_NN 18_CD ]_NN ._. To_TO generate_VB the_DT expression_NN plasmid_NN pET-GST-PPT_JJ 1_CD ,_,
          
          Saccharomyces_NNP cerevisiae_NN genomic_JJ
          DNA_NNP was_VBD used_VBN as_IN template_NN in_IN a_DT polymerase_NN chain_NN reaction_NN
          (_( PCR_NNP )_) with_IN 
          PPT_NNP 1_CD -_: specific_JJ oligonucleotide_NN
          primers_NNS ,_, (_( 5_CD '_POS primer_NN ,_, 5_CD '_POS -_: ATGtcaacacccacagcagcagat_NNP ;_: 3_CD '_POS
          primer_NN ,_, 5_CD '_POS -_: CTAtaaaccaaaaccaccattagaa_NNP )_) that_WDT contained_JJ
          initiation_NN and_CC stop_VB codons_NNS ,_, respectively_RB ._. A_DT PCR_NNP product_NN
          containing_VBG the_DT full-length_JJ 
          PPT_NNP 1_CD coding_VBG region_NN was_VBD then_RB cloned_VBN
          into_IN the_DT 
          Eco_NNP RV_NN restriction_NN site_NN of_IN pBII_NN KS_NNP
          -_: (_( Stratagene_NNP )_) and_CC sequenced_JJ ._. A_DT fragment_NN containing_VBG the_DT 
          PPT_NNP 1_CD ORF_NNP was_VBD excised_VBN from_IN the_DT
          pBII-PPT_JJ 1_CD using_VBG 
          Eco_NNP RI_NNP and_CC 
          Xho_NNP I_PRP restriction_NN enzymes_NNS and_CC was_VBD
          subcloned_JJ downstream_JJ of_IN the_DT GST_NNP coding_VBG region_NN into_IN the_DT 
          Eco_NNP RI_NNP and_CC 
          Sal_NNP I_PRP sites_NNS of_IN the_DT bacterial_JJ
          expression_NN vector_NN pET-_NN 21_CD a_DT GST_NNP [_NN 37_CD ]_NN ._. To_TO construct_VB the_DT
          pET-GST-PPT_JJ 1_CD (_( 1_CD -_: 504_CD )_) plasmid_NN a_DT 453_CD bp_NN fragment_NN was_VBD
          amplified_VBN from_IN pET-GST-PPT_JJ 1_CD by_IN PCR_NNP using_VBG a_DT 3_CD '_POS primer_NN
          containing_VBG a_DT 
          Xho_NNP I_PRP restriction_NN site_NN and_CC a_DT stop_NN
          codon_NN designed_VBN to_TO truncate_NN the_DT 
          PPT_NNP 1_CD gene_NN product_NN at_IN Met_NNP 504_CD
          (_( 5_CD '_POS -_: gatcctcgagTTAcattggttttatatctggg_NN )_) and_CC a_DT 5_CD '_POS primer_NN
          (_( 5_CD '_POS -_: gtaatgcatggtggttta_NN )_) encompassing_VBG the_DT 
          Nsi_NNP I_PRP restriction_NN site_NN of_IN 
          PPT_NNP 1_CD ._. The_DT PCR_NNP product_NN was_VBD cloned_VBN
          into_IN the_DT 
          Nsi_NNP I_PRP and_CC 
          Xho_NNP I_PRP restriction_NN sites_NNS of_IN
          pET-GST-PPT_JJ 1_CD and_CC sequenced_JJ ._. Each_DT construct_VB was_VBD
          transformed_VBN into_IN 
          E_NNP ._. coli_NNS strain_VBP BL_NNP 21_CD (_( DE_NNP 3_LS )_)
          (_( Novagen_NNP )_) ,_, and_CC protein_NN was_VBD expressed_VBN ,_, purified_JJ by_IN
          glutathione-agarose_JJ affinity_NN chromatography_NN ,_, cleaved_JJ from_IN
          GST_NNP and_CC stored_VBD in_IN 20_CD mM_NN Tris_NNP (_( pH_NN 7_CD ._. 6_CD at_IN 4_CD °_NN C_NNP )_) ,_, 50_CD %_NN
          glycerol_NN ,_, 1_CD mM_NN EGTA_NNP ,_, 0_CD ._. 1_CD %_NN 2_CD -_: mercaptoethanol_NN ,_, 4_CD mM_NN MnCl_NNP 
          2_CD at_IN -_: 20_CD °_NN C_NNP as_RB previously_RB described_VBD for_IN
          PP_NNP 5_CD [_NN 18_CD ]_NN ._. Recombinant_NNP Ppt_NNP 1_CD p_NN and_CC Ppt_NNP 1_CD p_NN (_( 1_CD -_: 504_CD )_) each_DT
          contain_VB an_DT additional_JJ seven_CD residues_NNS ,_,
          Gly-_NNP Ser-_NNP Gly-_NNP Ser-_NNP Glu-_NNP Phe-_NNP Asp_NNP ,_, which_WDT are_VBP remnants_NNS of_IN the_DT
          thrombin-cleavage_JJ site_NN ._. SDS-PAGE_NNP and_CC Coomassie_NNP stained_JJ
          gels_NNS showed_VBD that_IN full-length_JJ Ppt_NNP 1_CD p_NN and_CC Ppt_NNP 1_CD p_NN (_( 1_CD -_: 504_CD )_) each_DT
          constituted_VBD more_JJR than_IN 95_CD %_NN of_IN the_DT purified_JJ protein_NN (_( Fig_NNP ._.
          1_LS A_DT )_) ._.
        
        
          Phosphatase_NNP assays_NNS
          32_CD P-_NNP labeled_VBD substrates_NNS were_VBD prepared_VBN and_CC assays_NNS
          performed_VBN as_IN described_VBN previously_RB [_NN 18_CD ]_NN ._. Briefly_NNP ,_,
          protein_NN phosphatase_NN reactions_NNS contained_VBD 2_CD or_CC 4_CD nM_NN enzyme_NN
          in_IN a_DT final_JJ volume_NN of_IN 30_CD μl_NN containing_VBG buffer_NN A_DT (_( 50_CD mM_NN
          Tris_NNP ,_, pH_NN 7_CD ._. 6_CD ,_, 1_CD mM_NN EDTA_NNP ,_, 1_CD mM_NN EGTA_NNP ,_, 0_CD ._. 1_CD %_NN
          2_CD -_: mercaptoethanol_NN )_) ,_, 0_CD ._. 4_CD %_NN ethanol_NN and_CC 10_CD μM_NN radiolabeled_JJ
          phosphosubstrate_NN in_IN the_DT absence_NN or_CC presence_NN of_IN AA_NN [_NN 19_CD ]_NN
          ._. Reactions_NNP were_VBD initiated_VBN by_IN adding_VBG substrate_NN and_CC lipid_NN ,_,
          and_CC incubated_JJ at_IN 30_CD °_NN C_NNP for_IN 10_CD to_TO 15_CD min_NN ._. The_DT phosphate_NN
          released_VBN from_IN each_DT substrate_NN was_VBD less_JJR than_IN 20_CD %_NN of_IN the_DT
          total_JJ present_NN ._. The_DT amount_NN of_IN ethanol_NN added_VBD to_TO
          lipid-stimulated_JJ or_CC control_NN samples_NNS had_VBD no_DT effect_NN on_IN
          activity_NN ._.
        
        
          Limited_JJ proteolysis_NNS of_IN Ppt_NNP 1_CD p_NN
          Recombinant_NNP protein_NN was_VBD incubated_JJ with_IN either_DT trypsin_NN
          (_( Roche_NNP Molecular_NNP Biochemicals_NNP )_) or_CC subtilisin_NN (_( Roche_NNP
          Molecular_NNP Biochemicals_NNP )_) in_IN the_DT absence_NN or_CC presence_NN of_IN 250_CD
          μM_NN lipid_NN for_IN 0_CD to_TO 30_CD min_NN at_IN 30_CD °_NN C_NNP ,_, as_RB previously_RB described_VBD
          [_NN 19_CD ]_NN ._. To_TO assess_VB phosphatase_NN activity_NN ,_, an_DT aliquot_NN of_IN
          the_DT digestion_NN reaction_NN was_VBD diluted_VBN in_IN buffer_NN A_DT containing_VBG
          either_CC 0_CD ._. 1_CD mg_NN /_NN ml_NN soybean_NN trypsin_NN inhibitor_NN for_IN trypsin_NN ,_,
          or_CC 2_CD mM_NN PMSF_NNP for_IN subtilisin_NN and_CC assayed_JJ ._. Matched_NNP samples_NNS
          from_IN the_DT proteolysis_NNS reaction_NN were_VBD quenched_JJ with_IN
          trichloroacetic_JJ acid_NN (_( 10_CD %_NN ,_, w_NN /_NN v_NN )_) ,_, protein_NN was_VBD sedimented_JJ ,_,
          then_RB boiled_VBD in_IN (_( 75_CD mM_NN Tris-_NNP HCl_NNP ,_, pH_NN 6_CD ._. 8_CD ,_, 2_CD %_NN SDS_NNP ,_, 10_CD %_NN
          glycerol_NN ,_, 0_CD ._. 1_CD %_NN 2_CD -_: mercaptoethanol_NN and_CC 0_CD ._. 01_CD %_NN bromophenol_NN
          blue_JJ )_) ,_, subjected_VBN to_TO SDS-PAGE_NNP using_VBG 10_CD or_CC 15_CD %_NN resolving_VBG
          gels_NNS ,_, and_CC protein_NN bands_NNS visualized_JJ by_IN Coomassie_NNP staining_VBG ._.
          For_IN zero_CD time_NN points_NNS ,_, samples_NNS were_VBD withdrawn_VBN before_IN the_DT
          addition_NN of_IN protease_NN but_CC were_VBD otherwise_RB identical_JJ ._.
        
        
          N-_NNP terminal_NN sequence_NN analysis_NN of_IN proteolytic_JJ
          fragments_NNS
          Proteolytic_NNP fragments_NNS separated_VBN by_IN SDS-PAGE_NNP were_VBD
          transferred_VBN to_TO ProBlott_NNP PVDF_NNP membranes_NNS (_( Applied_NNP
          Biosystems_NNP ,_, Inc_NNP ._. )_) as_IN described_VBN by_IN LeGendre_NNP 
          et_CC al_NN [_NN 38_CD ]_NN ._. Coomassie-stained_NNP
          protein_NN bands_NNS were_VBD then_RB subjected_VBN to_TO sequence_NN analysis_NN
          using_VBG either_CC a_DT Model_NNP 491_CD or_CC Model_NNP 470_CD A_DT gas_NN phase_NN
          sequencer_NN equipped_VBN with_IN a_DT Model_NNP 120_CD A_DT on-line_JJ
          phenylthiohydantoin_NN analyzer_NN (_( Applied_NNP Biosystems_NNP ,_, Inc_NNP )_) ._.
          Sequence_NNP analysis_NN was_VBD performed_VBN in_IN the_DT Purdue_NNP
          Macromolecular_NNP Structure_NNP Facility_NNP ._.
        
        
          Cloning_NNP ,_, subcloning_VBG ,_, and_CC gene_NN replacement_NN for_IN the_DT
          expression_NN of_IN HA-Ppt_NNP 1_CD p_NN in_IN yeast_NN cells_NNS
          For_IN expression_NN of_IN HA-tagged_NNP Ppt_NNP 1_CD p_NN under_IN control_NN of_IN the_DT
          
          GAL_NNP 1_CD promoter_NN ,_, a_DT 
          PPT_NNP 1_CD DNA_NNP fragment_NN was_VBD cut_VBN from_IN
          pET-GST-PPT_JJ 1_CD by_IN 
          EcoR_NNP I_PRP and_CC 
          Not_RB I_PRP digestion_NN and_CC subcloned_JJ into_IN
          the_DT 
          EcoR_NNP I_PRP /_NN 
          Not_RB I-_NNP digested_VBN YCpIF_NNP 16_CD (_( ATCC_NNP No_UH ._.
          87091_CD )_) ,_, a_DT centromeric_JJ plasmid_NN ._. The_DT resulting_VBG plasmid_NN ,_,
          YCpIF_NNP 16_CD -_: PPT_NNP 1_CD ,_, was_VBD transformed_VBN into_IN yeast_NN W_NNP 303_CD cells_NNS (_( 
          MAT_NNP 
          a_DT ,_, 
          can_MD 1_CD -_: 100_CD ,_, leu_NN 2_CD -_: 3_CD ,_, 112_CD ,_, his_PRP$ 3_CD -_: 11_CD ,_, 15_CD ,_,
          trp_NN 1_CD -_: 1_CD ,_, ura_NN 3_CD -_: 1_CD ,_, ade_NN 2_CD -_: 1_LS )_) ._. Transformed_NNP cells_NNS were_VBD
          grown_VBN in_IN SC-Trp_NNP medium_NN at_IN 30_CD °_NN C_NNP to_TO OD_NNP 
          600_CD nm_NN 0_CD ._. 5_CD ,_, washed_VBD twice_RB to_TO remove_VB
          glucose_NN ,_, then_RB grown_VBN in_IN SG-Trp_NNP medium_NN containing_VBG 2_CD %_NN
          galactose_NN instead_RB of_IN glucose_NN for_IN 12_CD -_: 16_CD hr_NN at_IN room_NN
          temperature_NN to_TO induce_VB protein_NN expression_NN ._.
          A_DT strain_NN expressing_VBG HA-Ppt_NNP 1_CD p_NN was_VBD made_VBN using_VBG the_DT
          two-step_JJ gene_NN replacement_NN strategy_NN [_NN 39_CD ]_NN ._. First_CD ,_, the_DT
          upstream_JJ sequence_NN of_IN 
          PPT_NNP 1_CD (_( -_: 955_CD to_TO -_: 1_LS )_) was_VBD amplified_VBN
          from_IN yeast_NN genomic_JJ DNA_NNP by_IN PCR_NNP using_VBG a_DT 5_CD '_POS primer_NN
          containing_VBG a_DT 
          Kpn_NNP I_PRP restriction_NN site_NN
          (_( 5_CD '_POS -_: gatcGGTACCattagcacggtgccttaacca-_NN 3_CD '_POS )_) and_CC a_DT 3_CD '_POS primer_NN
          containing_VBG a_DT 
          Xho_NNP I_PRP site_NN and_CC HA_NNP coding_VBG sequence_NN
          (_( 5_CD '_POS -_: gatcCTCGAGatcgataccgtcgagctagcgtagtctgggacgtcgtatgggtatcgactcatATTCGAGATATTTGATTATACCAAGGC-_NN 3_CD '_POS )_) ._.
          In_IN the_DT 3_CD '_POS primer_NN ,_, the_DT sequence_NN from_IN the_DT 
          Xho_NNP I_PRP restriction_NN site_NN to_TO the_DT HA_NNP
          coding_VBG sequence_NN was_VBD identical_JJ to_TO that_DT present_JJ in_IN YCpIF_NNP 16_CD ._.
          The_DT amplified_VBN DNA_NNP fragment_NN was_VBD cloned_VBN into_IN pRS_NN 306_CD (_( New_NNP
          England_NNP Biolabs_NNP ,_, Inc_NNP ._. )_) using_VBG 
          Kpn_NNP I_PRP and_CC 
          Xho_NNP I_PRP restriction_NN sites_NNS to_TO generate_VB
          pRS_NN 306_CD -_: 955_CD HA_NNP ._. Then_RB ,_, a_DT fragment_NN containing_VBG the_DT 
          PPT_NNP 1_CD ORF_NNP was_VBD excised_VBN from_IN
          YCpIF_NNP 16_CD -_: PPT_NNP 1_CD by_IN 
          Xho_NNP I_PRP and_CC 
          Not_RB I_PRP digestion_NN and_CC subcloned_JJ into_IN
          this_DT plasmid_NN to_TO form_VB pRS_NN 306_CD -_: 955_CD HAPPT_NNP 1_CD ._. The_DT plasmid_NN was_VBD
          linearized_JJ by_IN 
          Bam_UH HI_NNP digestion_NN ,_, transformed_VBN into_IN
          the_DT yeast_NN strain_NN ,_, W_NNP 303_CD ,_, and_CC the_DT transformed_VBN cells_NNS were_VBD
          plated_JJ on_IN a_DT SC-Ura_NNP plate_NN ._. The_DT resulting_VBG colonies_NNS were_VBD
          then_RB grown_VBN in_IN YPAD_NNP media_NNS (_( 1_CD %_NN yeast_NN extract_NN ,_, 2_CD %_NN peptone_NN ,_,
          0_CD ._. 04_CD %_NN adenine_NN ,_, and_CC 2_CD %_NN glucose_NN )_) and_CC plated_JJ on_IN 5_CD -_: FOA_NNP plates_NNS
          to_TO select_VB clones_NNS emerging_VBG by_IN a_DT second_JJ recombination_NN event_NN
          that_WDT eliminated_VBD the_DT 
          URA_NNP 3_CD gene_NN together_RB with_IN the_DT
          additional_JJ copy_NN of_IN 
          PPT_NNP 1_CD ._. To_TO confirm_VB gene_NN replacement_NN ,_,
          chromosomal_NN DNA_NNP from_IN these_DT clones_NNS was_VBD used_VBN for_IN PCR_NNP
          amplification_NN of_IN the_DT region_NN encoding_VBG HA-Ppt_NNP 1_CD p_NN ._. Amplified_NNP
          product_NN was_VBD then_RB analyzed_VBN by_IN 
          Xho_NNP I_PRP digest_VB ,_, which_WDT can_MD only_RB cut_VB
          amplified_VBN product_NN from_IN the_DT replaced_VBN gene_NN ._.
        
        
          Immunoblotting_NNP and_CC immunocytochemical_JJ analysis_NN of_IN
          HA-Ppt_NNP 1_CD p_NN expression_NN
          Wild_NNP type_NN (_( W_NNP 303_CD )_) cell_NN and_CC WHT_NNP 4_CD -_: 1_CD cells_NNS were_VBD grown_VBN in_IN
          YPAD_NNP medium_NN ._. The_DT expression_NN of_IN HA-Ppt_NNP 1_CD p_NN was_VBD detected_VBN by_IN
          immunoblot_NN using_VBG the_DT 12_CD CA_NNP 5_CD monoclonal_NN anti-_NN HA_NNP antibody_NN
          (_( Roche_NNP Molecular_NNP Biochemicals_NNP )_) ._. The_DT total_JJ protein_NN was_VBD
          extracted_VBN from_IN approximately_RB 10_CD 7_CD cells_NNS by_IN vortexing_VBG with_IN
          glass_NN beads_NNS ,_, then_RB resolved_VBN by_IN SDS-PAGE_NNP on_IN 12_CD %_NN gel_NN ,_, and_CC
          transferred_VBD to_TO nitrocellulose_NN at_IN 55_CD V_NNP in_IN (_( 25_CD mM_NN Tris_NNP ,_, 250_CD
          mM_NN glycine_NN ,_, 0_CD ._. 1_CD %_NN SDS_NNP ,_, and_CC 20_CD %_NN methanol_NN )_) for_IN 1_CD hr_NN at_IN room_NN
          temperature_NN ._. The_DT membrane_NN was_VBD blocked_VBN with_IN 3_CD %_NN non-fat_JJ dry_JJ
          milk_NN (_( Bio-_NNP Rad_NNP )_) ,_, 0_CD ._. 1_CD %_NN tween-_NN 20_CD in_IN TBS_NNP (_( pH_NN 7_CD ._. 4_LS )_) ,_, then_RB cut_VB
          at_IN molecular_JJ weight_NN marker_NN 45_CD kDa_NN ._. The_DT upper_JJ half_NN was_VBD
          probed_JJ with_IN anti-_NN HA_NNP antibody_NN (_( 4_CD μg_NN /_NN ml_NN )_) ,_, followed_VBN by_IN
          HRP-conjugated_NNP anti-mouse_JJ IgG_NNP (_( 1_CD :_: 5_CD ,_, 000_CD ,_, CalBiochem_NNP )_) ,_, and_CC
          the_DT signal_NN was_VBD detected_VBN using_VBG ECL_NNP reagents_NNS (_( Amersham_NNP
          Pharmacia_NNP Biotech_NNP UK_NNP Ltd_NNP ._. )_) ._. The_DT lower_JJR half_NN was_VBD probed_JJ
          with_IN anti-_NN Cdc_NNP 28_CD p_NN antibody_NN (_( Santa_NNP Cruz_NNP Biotechnology_NNP )_) to_TO
          ensure_VB that_IN an_DT equal_JJ amount_NN of_IN protein_NN was_VBD loaded_VBN in_IN each_DT
          lane_NN ._. The_DT relative_JJ level_NN of_IN HA-Ppt_NNP 1_CD p_NN expression_NN was_VBD
          determined_VBN by_IN comparing_VBG the_DT band_NN intensity_NN of_IN HA-Ppt_NNP 1_CD p_NN to_TO
          that_DT of_IN Cdc_NNP 28_CD p_NN using_VBG ImageQuant_NNP software_NN version_NN 5_CD ._. 1_CD
          (_( Molecular_NNP Dynamics_NNP )_) ._.
          Cells_NNP were_VBD prepared_VBN for_IN immunocytochemistry_NN as_IN
          described_VBN by_IN Harlow_NNP and_CC Lane_NNP [_NN 40_CD ]_NN ._. Briefly_NNP ,_, WHT_NNP 4_CD -_: 1_CD
          cells_NNS were_VBD grown_VBN to_TO early_JJ log-phase_JJ (_( OD_NNP 
          600_CD nm_NN 1_CD ._. 0_CD -_: 1_CD ._. 5_LS )_) ,_, fixed_VBN by_IN 4_CD %_NN
          para-formaldehyde_JJ ,_, and_CC the_DT cell_NN wall_NN was_VBD removed_VBN by_IN
          treatment_NN with_IN β-glucuronidase_JJ and_CC zymolase_NN ._. The_DT
          resulting_VBG spheroplasts_NNS were_VBD attached_VBN to_TO poly-_NN L-_NNP lysine_NN
          coated_JJ coverslips_NNS and_CC treated_VBN with_IN cold_JJ methanol_NN ,_, then_RB
          acetone_NN ._. After_IN blocking_VBG non-specific_JJ binding_JJ sites_NNS with_IN
          3_CD %_NN BSA_NNP ,_, 0_CD ._. 1_CD %_NN tween-_NN 20_CD in_IN PBS_NNP ,_, the_DT coverslips_NNS were_VBD
          incubated_JJ with_IN anti-_NN HA_NNP (_( 40_CD μg_NN /_NN ml_NN )_) or_CC anti-_NN GFP_NNP antibody_NN
          (_( 40_CD μg_NN /_NN ml_NN )_) ,_, rabbit_NN anti-mouse_JJ IgG_NNP (_( Pierce_NNP ,_, 1_CD :_: 200_CD )_) ,_,
          biotin-conjugated_JJ anti-rabbit_JJ IgG_NNP (_( Vector_NNP Laboratories_NNPS ,_,
          1_CD :_: 200_CD )_) ,_, and_CC streptavidin_NN conjugated_JJ with_IN either_DT Alexa_NNP 488_CD
          or_CC Alexa_NNP 594_CD (_( Molecular_NNP Probes_NNP ,_, 1_CD :_: 200_CD )_) ._. After_IN staining_VBG
          nuclei_NN with_IN 4_CD '_POS 6_CD -_: diamidino-_NN 2_CD -_: phenylindole_NN (_( DAPI_NNP )_) ,_, the_DT
          coverslips_NNS were_VBD mounted_VBN on_IN slides_NNS using_VBG ProLong_NNP anti-fade_JJ
          reagent_NN (_( Molecular_NNP Probes_NNP )_) ._. The_DT specimens_NNS were_VBD examined_VBN
          with_IN a_DT BX_NNP 60_CD fluorescence_NN microscope_NN (_( Olympus_NNP )_) and_CC images_NNS
          captured_VBD using_VBG a_DT RT_NNP 220_CD color_NN digital_JJ camera_NN (_( Diagnostic_NNP
          Instruments_NNP ,_, Inc_NNP ._. )_) ._. W_NNP 303_CD cells_NNS treated_VBN in_IN the_DT same_JJ manner_NN
          were_VBD used_VBN as_IN a_DT negative_JJ control_NN ._.
        
        
          Northern_JJ blot_NN analysis_NN of_IN PPT_NNP 1_CD mRNA_NN
          Total_NNP RNA_NNP was_VBD prepared_VBN from_IN W_NNP 303_CD and_CC WHT_NNP 4_CD -_: 1_CD yeast_NN
          cells_NNS using_VBG hot_JJ acid_NN phenol_NN extraction_NN [_NN 41_CD ]_NN ._. For_IN
          electrophoresis_NNS ,_, 20_CD μg_NN of_IN RNA_NNP per_IN sample_NN was_VBD resolved_VBN on_IN
          a_DT 1_CD %_NN agarose_NN gel_NN containing_VBG 2_CD ._. 2_CD M_NNP formaldehyde_NN at_IN 5_CD V_NNP /_NN cm_NN
          until_IN the_DT bromophenol_NN blue_JJ migrated_JJ 8_CD cm_NN ._. The_DT gel_NN was_VBD
          rinsed_JJ with_IN diethylpyrocarbonate-treated_JJ H_NNP 
          2_CD O_NNP and_CC the_DT RNA_NNP was_VBD transferred_VBN to_TO a_DT
          Hybond_NNP N_NNP +_NN membrane_NN (_( Amersham_NNP Biosciences_NNP )_) by_IN capillary_JJ
          transfer_NN in_IN alkaline_NN solution_NN (_( 0_CD ._. 01_CD N_NNP NaOH_NNP ,_, 3_CD M_NNP NaCl_NNP )_) for_IN
          overnight_JJ ._. The_DT membrane_NN was_VBD pre-hybridized_JJ with_IN
          PERFECTHYB_NNP PLUS_NNP solution_NN (_( Sigma_NNP )_) at_IN 68_CD °_NN C_NNP for_IN 1_CD hr_NN ,_, and_CC a_DT
          cDNA_NN probe_NN for_IN 
          PPT_NNP 1_CD was_VBD added_VBN and_CC incubated_JJ at_IN
          42_CD °_NN C_NNP for_IN overnight_JJ ._. The_DT cDNA_NN probe_NN was_VBD prepared_VBN by_IN
          restriction_NN digestion_NN of_IN pET-GST-PPT_JJ 1_CD with_IN 
          Bsm_NNP I_PRP and_CC 
          Nco_NNP I_PRP ._. The_DT 879_CD bp_NN DNA_NNP fragment_NN
          generated_VBD ,_, corresponding_JJ to_TO 544_CD -_: 1422_CD of_IN 
          PPT_NNP 1_CD coding_VBG sequence_NN ,_, was_VBD
          gel-purified_JJ and_CC labeled_VBN with_IN 0_CD ._. 67_CD μM_NN [_NN α-_NN 32_CD P_NN ]_NN CTP_NNP (_( 3000_CD
          Ci_NNP /_NN mmol_NN )_) using_VBG the_DT DECAprimeII_NNP random_JJ priming_VBG kit_NN
          (_( Ambion_NNP )_) according_VBG to_TO the_DT user_NN manual_JJ ._. After_IN washing_VBG with_IN
          1_CD ×_NN SSC_NNP ,_, 0_CD ._. 1_CD %_NN SDS_NNP for_IN 20_CD min_NN at_IN room_NN temperature_NN and_CC 0_CD ._. 2_CD
          ×_NN SSC_NNP ,_, 0_CD ._. 1_CD %_NN SDS_NNP for_IN 20_CD min_NN three_CD times_NNS at_IN 68_CD °_NN C_NNP ,_, the_DT
          membrane_NN was_VBD exposed_VBN to_TO a_DT storage_NN phosphor_NN screen_NN GP_NNP
          (_( Kodak_NNP )_) or_CC x-ray_JJ film_NN (_( BMS_NNP 1_CD ,_, Kodak_NNP )_) ._. The_DT membrane_NN was_VBD
          stripped_VBN in_IN 50_CD %_NN formamide_NN ,_, 0_CD ._. 1_CD ×_NN SSC_NNP ,_, 0_CD ._. 1_CD %_NN SDS_NNP for_IN 2_CD hr_NN
          at_IN 68_CD °_NN C_NNP ,_, and_CC reprobed_JJ with_IN a_DT cDNA_NN for_IN 
          ACT_NNP 1_CD (_( yeast_NN actin_NN gene_NN )_) ._. The_DT DNA_NNP
          fragment_NN corresponding_JJ 214_CD -_: 694_CD of_IN actin_NN coding_VBG sequence_NN
          was_VBD amplified_VBN by_IN PCR_NNP using_VBG yeast_NN genomic_JJ DNA_NNP as_IN template_NN
          and_CC 
          ACT_NNP 1_CD -_: specific_JJ oligonucleotide_NN
          primers_NNS (_( 5_CD '_POS primer_NN ,_,
          5_CD '_POS -_: gaacacggtattgtcaccaactgggacgatatgg_NN ;_: 3_CD '_POS primer_NN ,_,
          5_CD '_POS -_: gagcagcggtttgcatttcttgttcgaagtcc_NN )_) ._. The_DT 481_CD bp_NN DNA_NNP
          fragment_NN was_VBD labeled_VBN and_CC used_VBN essentially_RB as_IN described_VBN
          for_IN the_DT 
          PPT_NNP 1_CD probe_NN ._. The_DT storage_NN phosphor_NN
          screen_NN was_VBD scanned_JJ using_VBG Typhoon_NNP scanner_NN (_( Molecular_NNP
          Dynamics_NNP )_) ,_, and_CC the_DT relative_JJ level_NN of_IN 
          PPT_NNP 1_CD message_NN was_VBD determined_VBN by_IN
          comparing_VBG the_DT band_NN intensity_NN of_IN 
          PPT_NNP 1_CD mRNA_NN to_TO that_DT of_IN actin_NN mRNA_NN
          using_VBG ImageQuant_NNP software_NN version_NN 5_CD ._. 1_CD (_( Molecular_NNP
          Dynamics_NNP )_) ._.
        
      
      
        List_NN of_IN abbreviations_NNS
        PP_NNP ,_, protein_NN phosphatase_NN ;_: MBP_NNP ,_, myelin_NN basic_JJ protein_NN ;_: TPR_NNP ,_,
        tetratricopeptide_NN repeat_NN ;_: AA_NN ,_, arachidonic_JJ acid_NN ;_: HA_NNP ,_,
        hemagglutinin_NN ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
      
        Authors_NNP '_'' contributions_NNS
        JYJ_NNP cloned_VBN ,_, expressed_VBD ,_, and_CC performed_VBD initial_JJ
        characterization_NN studies_NNS of_IN recombinant_JJ Ppt_NNP 1_CD p_NN ,_, performed_VBN
        gene_NN replacement_NN ,_, immunoblot_NN and_CC immunolocalization_NN
        studies_NNS ,_, and_CC prepared_VBD the_DT manuscript_NN ._. JJ_NNP and_CC CS_NNP
        characterized_VBD PPT_NNP 1_CD activity_NN following_VBG truncation_NN or_CC limited_JJ
        proteolysis_NNS and_CC identified_VBN proteolysis_NNS sites_NNS ._. JYJ_NNP and_CC JMP_NNP
        carried_VBD out_RP Northern_NNP blot_NN analyses_NNS ._. SR_NNP helped_VBD design_NN ,_,
        supervise_VB and_CC interpret_VB studies_NNS and_CC with_IN manuscript_NN
        preparation_NN ._. All_DT authors_NNS read_VBP and_CC approved_VBD the_DT final_JJ
        manuscript_NN ._.
      
    
  
